Please provide your email address to receive an email when new articles are posted on . The onset of the COVID-19 pandemic forced health care systems to adapt clinical practice to limit patient ...

Self-testing of anticoagulation improves outcomes, but is expensive. One might assume it is more helpful for patients living farther from care, but the authors disprove this assumption. Objectives: ...

Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

Warfarin is an anti-coagulant prescribed to people with various heart conditions and those who have experienced or are at high risk for a blood clot. Anti-coagulants are also referred to as “blood ...

First of all, I want to congratulate Drs. Matchar and Jacobson for a very important trial and one that will eventually help those of us who are proponents of home INR testing to drive the change so ...

Exemption of the system from virtually all CLIA rules gives more labs access to connectivity and data management capabilities for monitoring patients on warfarin therapy INDIANAPOLIS, Oct. 1, 2012 ...

(MENAFN- EIN Presswire) EINPresswire/ -- The market outlook reflects the UK healthcare system's continued reliance on INR monitoring as a core clinical control for anticoagulation management, ...

The assessment consisted of a systematic review of the evidence on test performance and clinical‑effectiveness data for the CoaguChek XS system, the INRatio2 PT/INR monitor, the ProTime ...

The market for home healthcare devices is growing at a steady clip, and Roche ($RHHBY) is wise to the trend. The Swiss diagnostics giant is launching its PT/INR home ...